Back
ProQR Therapeutics NV Stock Price Chart
Final Days: Should You Invest in This AI Startup Now?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
7
PRQR
ProQR Therapeutics NV
Last Price:
$1.34
Seasonality Move:
1.19%
7 Day Trial
ALL ACCESS PASS
$
7
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight selling pressure.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.53 | Sell |
| 20-day SMA: | 1.72 | Sell |
| 50-day SMA: | 2.06 | Sell |
| 200-day SMA: | 2.34 | Sell |
| 8-day EMA: | 1.5 | Sell |
| 20-day EMA: | 1.71 | Sell |
| 50-day EMA: | 2.04 | Sell |
| 200-day EMA: | 2.31 | Sell |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 18.4 | Sell |
| Chaikin Money Flow: | -156273 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.52 - 2.18) | Sell |
| Bollinger Bands (100): | (1.92 - 3.38) | Sell |
ProQR Therapeutics NV Technical Analysis
| Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 1.33 while PRQR 8-day simple moving average is 1.53, which is a Sell signal.
-
The stock price of PRQR is 1.33 while ProQR Therapeutics NV 20-day SMA is 1.72, which makes it a Sell.
-
ProQR Therapeutics NV 50-day simple moving average is 2.06 while PRQR share price is 1.33, making it a Sell technically.
-
PRQR stock price is 1.33 and ProQR Therapeutics NV 200-day simple moving average is 2.34, creating a Sell signal.
PRQR Technical Analysis vs Fundamental Analysis
Sell
7
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a SellThe current ProQR Therapeutics NV [PRQR] share price is $1.33. The Score for PRQR is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
139.9M
Price in USD:
1.33
Share Volume:
781.4K
ProQR Therapeutics NV 52-Week Range
52-Week High:
4.62
52-Week Low:
1.29
Sell
7
ProQR Therapeutics NV (PRQR)
is a Sell
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?The ProQR Therapeutics NV stock price is 1.33 USD today.
-
Will PRQR stock go up or go down?ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators
-
Is ProQR Therapeutics NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is overvalued.
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 1.33 while PRQR 8-day exponential moving average is 1.50, which is a Sell signal.
-
The stock price of PRQR is 1.33 while ProQR Therapeutics NV 20-day EMA is 1.71, which makes it a Sell.
-
ProQR Therapeutics NV 50-day exponential moving average is 2.04 while PRQR share price is 1.33, making it a Sell technically.
-
PRQR stock price is 1.33 and ProQR Therapeutics NV 200-day simple moving average is 2.31, creating a Sell signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.07 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
-
PRQR Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting ProQR Therapeutics NV is a Sell
-
ProQR Therapeutics NV Relative Strength Index (RSI) is 18.4, which suggest ProQR Therapeutics NV is oversold
-
The Bollinger Bands (25) for ProQR Therapeutics NV is (1.52 - 2.18), which suggest ProQR Therapeutics NV is a Sell
-
The Bollinger Bands (100) for ProQR Therapeutics NV is (1.92 - 3.38), which suggest ProQR Therapeutics NV is a Sell
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.